Showing results (91-100 of 196) with videos related to
Sort By:
Pageof 20
Cancer Discovery|September 8, 2012
HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutationKen Takezawa, Valentina Pirazzoli, Maria E Arcila, et al.The Journal of Molecular Diagnostics : JMD|March 25, 2022
Defining Novel DNA Virus-Tumor Associations and Genomic Correlates Using Prospective Clinical Tumor/Normal Matched Sequencing DataChad M Vanderbilt, Anita S Bowman, Sumit Middha, et al.Blood Advances|May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasmsNatasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2015
A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung CancerAlexander Drilon, Romel Somwar, Jacob P Wagner, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2019
Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung CancersMorana Vojnic, Daisuke Kubota, Christopher Kurzatkowski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung CancerKen Suzawa, Michael Offin, Daniel Lu, et al.Blood Advances|February 2, 2018
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemiaPeter G Maslak, Tao Dao, Yvette Bernal, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2019
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical OutcomesMichael Offin, Joseph M Chan, Megan Tenet, et al.Leukemia|October 20, 2019
Prognostic impact of RAS-pathway mutations in patients with myelofibrosisFabio P S Santos, Bartlomiej Getta, Lucia Masarova, et al.Blood Advances|June 13, 2025
BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implantsPaola Ghione, Diana Mandelker, Maria E Arcila, et al.Pageof 20